These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 14673869

  • 1. Modulation of plasma lipid levels affects benzo[a]pyrene-induced DNA damage in tissues of two hyperlipidemic mouse models.
    Curfs DM, Beckers L, Godschalk RW, Gijbels MJ, van Schooten FJ.
    Environ Mol Mutagen; 2003; 42(4):243-9. PubMed ID: 14673869
    [Abstract] [Full Text] [Related]

  • 2. Decreased levels of lipid peroxidation-induced DNA damage in the onset of atherogenesis in apolipoprotein E deficient mice.
    Godschalk RW, Albrecht C, Curfs DM, Schins RP, Bartsch H, van Schooten FJ, Nair J.
    Mutat Res; 2007 Aug 01; 621(1-2):87-94. PubMed ID: 17418875
    [Abstract] [Full Text] [Related]

  • 3. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.
    Circ Res; 2009 Sep 25; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [Abstract] [Full Text] [Related]

  • 4. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.
    van Vlijmen BJ, van den Maagdenberg AM, Gijbels MJ, van der Boom H, HogenEsch H, Frants RR, Hofker MH, Havekes LM.
    J Clin Invest; 1994 Apr 25; 93(4):1403-10. PubMed ID: 8163645
    [Abstract] [Full Text] [Related]

  • 5. Benzo[a]pyrene enhances lipid peroxidation induced DNA damage in aorta of apolipoprotein E knockout mice.
    Godschalk R, Curfs D, Bartsch H, Van Schooten FJ, Nair J.
    Free Radic Res; 2003 Dec 25; 37(12):1299-305. PubMed ID: 14753754
    [Abstract] [Full Text] [Related]

  • 6. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.
    van Vlijmen BJ, Pearce NJ, Bergö M, Staels B, Yates JW, Gribble AD, Bond BC, Hofker MH, Havekes LM, Groot PH.
    Arzneimittelforschung; 1998 Apr 25; 48(4):396-402. PubMed ID: 9608883
    [Abstract] [Full Text] [Related]

  • 7. Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: Role of downregulation of CD40 and MMP-9 expression.
    Liu G, Wang B, Zhang J, Jiang H, Liu F.
    J Ethnopharmacol; 2009 Nov 12; 126(2):350-4. PubMed ID: 19703533
    [Abstract] [Full Text] [Related]

  • 8. Persistence of benzo(a)pyrene metabolite:DNA adducts in lung and liver of mice.
    Kulkarni MS, Anderson MW.
    Cancer Res; 1984 Jan 12; 44(1):97-101. PubMed ID: 6317174
    [Abstract] [Full Text] [Related]

  • 9. Exposure-route-dependent DNA adduct formation by polycyclic aromatic hydrocarbons.
    Godschalk RW, Moonen EJ, Schilderman PA, Broekmans WM, Kleinjans JC, Van Schooten FJ.
    Carcinogenesis; 2000 Jan 12; 21(1):87-92. PubMed ID: 10607738
    [Abstract] [Full Text] [Related]

  • 10. Osteopontin gene expression in the aorta and the heart of propylthiouracil-induced hypothyroid mice.
    Liou YM, Chang LY, Liaw JM, Jiang MJ.
    J Biomed Sci; 2005 Dec 12; 12(6):869-80. PubMed ID: 16265595
    [Abstract] [Full Text] [Related]

  • 11. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
    Raffai RL, Loeb SM, Weisgraber KH.
    Arterioscler Thromb Vasc Biol; 2005 Feb 12; 25(2):436-41. PubMed ID: 15591220
    [Abstract] [Full Text] [Related]

  • 12. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
    Kitayama K, Nishizawa T, Abe K, Wakabayashi K, Oda T, Inaba T, Amemiya Y.
    J Pharm Pharmacol; 2006 Dec 12; 58(12):1629-38. PubMed ID: 17331327
    [Abstract] [Full Text] [Related]

  • 13. DNA adduct kinetics in reproductive tissues of DNA repair proficient and deficient male mice after oral exposure to benzo(a)pyrene.
    Verhofstad N, van Oostrom CT, van Benthem J, van Schooten FJ, van Steeg H, Godschalk RW.
    Environ Mol Mutagen; 2010 Mar 12; 51(2):123-9. PubMed ID: 19634154
    [Abstract] [Full Text] [Related]

  • 14. Diet-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction, and premature death in scavenger receptor class B type I-deficient, hypomorphic apolipoprotein ER61 mice.
    Zhang S, Picard MH, Vasile E, Zhu Y, Raffai RL, Weisgraber KH, Krieger M.
    Circulation; 2005 Jun 28; 111(25):3457-64. PubMed ID: 15967843
    [Abstract] [Full Text] [Related]

  • 15. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
    Harrington SC, Simari RD, Conover CA.
    Circ Res; 2007 Jun 22; 100(12):1696-702. PubMed ID: 17510462
    [Abstract] [Full Text] [Related]

  • 16. 32P-postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene.
    Lu LJ, Disher RM, Reddy MV, Randerath K.
    Cancer Res; 1986 Jun 22; 46(6):3046-54. PubMed ID: 3698023
    [Abstract] [Full Text] [Related]

  • 17. Effects of simvastatin on plasma lipoproteins and hearing loss in apolipoprotein E gene-deficient mice.
    Cai Q, Du X, Zhou B, Cai C, Kermany MH, Zhang C, Yoo T.
    ORL J Otorhinolaryngol Relat Spec; 2009 Jun 22; 71(5):244-50. PubMed ID: 19738398
    [Abstract] [Full Text] [Related]

  • 18. Chronic exposure to the carcinogenic compound benzo[a]pyrene induces larger and phenotypically different atherosclerotic plaques in ApoE-knockout mice.
    Curfs DM, Lutgens E, Gijbels MJ, Kockx MM, Daemen MJ, van Schooten FJ.
    Am J Pathol; 2004 Jan 22; 164(1):101-8. PubMed ID: 14695324
    [Abstract] [Full Text] [Related]

  • 19. Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels.
    Ross JA, Nelson GB, Wilson KH, Rabinowitz JR, Galati A, Stoner GD, Nesnow S, Mass MJ.
    Cancer Res; 1995 Mar 01; 55(5):1039-44. PubMed ID: 7866986
    [Abstract] [Full Text] [Related]

  • 20. Chemoprevention of carcinogen-DNA adducts and chronic degenerative diseases.
    Izzotti A, D'Agostini F, Bagnasco M, Scatolini L, Rovida A, Balansky RM, Cesarone CF, De Flora S.
    Cancer Res; 1994 Apr 01; 54(7 Suppl):1994s-1998s. PubMed ID: 8137327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.